Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
164.49
+2.16 (1.33%)
At close: Mar 9, 2026, 4:00 PM EDT
164.63
+0.14 (0.09%)
After-hours: Mar 9, 2026, 7:19 PM EDT

Axsome Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-183.17-287.22-239.24-187.13-130.4
Upgrade
Depreciation & Amortization
9.067.966.834.40.08
Upgrade
Other Amortization
1.32.642.571.481.08
Upgrade
Stock-Based Compensation
93.7585.2262.6237.7320.8
Upgrade
Other Operating Activities
8.7129.5150.373.34-0.1
Upgrade
Change in Accounts Receivable
-82.46-47.18-57.12-37.7-
Upgrade
Change in Inventory
-10.660.74-8.16-1.33-
Upgrade
Change in Accounts Payable
-6.4631.322.0725.46-0.36
Upgrade
Change in Other Net Operating Assets
76.5348.634.9737.240.68
Upgrade
Operating Cash Flow
-93.41-128.41-145.08-116.51-108.23
Upgrade
Capital Expenditures
-0.48-0.27-0.58-0.7-0.31
Upgrade
Cash Acquisitions
----53-
Upgrade
Investing Cash Flow
-0.48-0.27-0.58-53.7-0.31
Upgrade
Long-Term Debt Issued
330-8545-
Upgrade
Long-Term Debt Repaid
-334.11-0.99---
Upgrade
Total Debt Repaid
-334.11-0.99---
Upgrade
Net Debt Issued (Repaid)
-4.11-0.998545-
Upgrade
Issuance of Common Stock
127.4671.46271.17250.0111.84
Upgrade
Repurchase of Common Stock
-7.11-3.95-1.84-0.53-0.18
Upgrade
Other Financing Activities
-14.78-8.68-23.32-9.9-0.53
Upgrade
Financing Cash Flow
101.4757.84331.01284.5811.13
Upgrade
Net Cash Flow
7.58-70.84185.35114.37-97.4
Upgrade
Free Cash Flow
-93.89-128.68-145.66-117.21-108.53
Upgrade
Free Cash Flow Margin
-14.70%-33.36%-53.83%-234.25%-
Upgrade
Free Cash Flow Per Share
-1.89-2.69-3.21-2.88-2.88
Upgrade
Cash Interest Paid
14.6319.6916.737.694.63
Upgrade
Levered Free Cash Flow
-29.42-38.1-87.21-43.82-59.52
Upgrade
Unlevered Free Cash Flow
-20.77-27.25-77.26-39.26-57.04
Upgrade
Change in Working Capital
-23.0633.48-28.2423.670.32
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.